undamentalytics Newsletter

Funds (13F)

Antipodes Partners Ltd

Backtest from 13 Jan 2017 to 2 Nov 2026 · weekly · hypothetical

Watch this strategy
Return a year
+15.5%
S&P 500 +14.8%
Last 12 months
+16.8%
S&P 500 +12.1%
Sharpe ratio
0.71
S&P 500 0.72
Biggest drop
−33.5%
S&P 500 −31.8%
$10.0k$20.0k$40.0k 20172019202120232025 $41.1k$38.8k
Antipodes Partners LtdS&P 500 $10,000 in Antipodes Partners Ltd from 13 Jan 2017 against the S&P 500 (total return) over the same dates, marked weekly, log scale. Hypothetical: before taxes and trading costs.

About

Copies Antipodes Partners Ltd's quarterly 13F holdings in the companies we cover, weighted by reported value: it buys on the first trading day after each 13F is filed (up to 45 days after the quarter) and holds until the next filing. A 13F shows long US-listed positions only, at the quarter's end, so this misses shorts, cash, bonds, non-US holdings and trading within the quarter.

Antipodes Partners Ltd's 13F holdings →

Key statistics

MeasureStrategyS&P 500
Return a year (compound)+15.5%+14.8%
Total return+311%+288%
Last 12 months+16.8%+12.1%
Last 3 months+2.4%—
Last month+4.6%—
This year so far+10.9%—
Volatility a year18.8%17.4%
Sharpe ratio0.710.72
Biggest drop−33.5%−31.8%
Beta to the S&P 5000.961.00
Alpha a year (t-statistic)+1.3% (0.47)—
Share of weeks up57%—

Sharpe ratio uses returns above the 3-month Treasury bill rate. Alpha is the yearly return left after allowing for the strategy's exposure to the S&P 500 (CAPM); a t-statistic below about 2 means it cannot be told apart from luck.

Insights

CompanyWeightHeld sinceReturn since
AMZN4.6%——
AEP4.5%——
COF3.8%——
NVDA3.6%——
EXC3.6%——
FER3.6%——
BKD3.5%——
SRE3.2%——
MSFT2.9%——
AEE2.8%——
MRK2.7%——
B2.7%——
KEYS2.5%——
CCI2.5%——
WTRG2.4%——
ETR2.4%——
HCA2.2%——
D2.1%——
HTO2.1%——
LNG2.0%——
DUK2.0%——
NI2.0%——
META2.0%——
ENB2.0%——
CART2.0%——
BKNG1.8%——
EVRG1.6%——
EAT1.5%——
CRM1.5%——
DIS1.5%——
AMT1.4%——
SLB1.4%——
VAL1.4%——
ALLY1.4%——
GMED1.4%——
KDP1.3%——
NU1.2%——
VTR1.0%——
EGO1.0%——
PGR1.0%——
ALNY0.9%——
CWT0.7%——
DT0.6%——
HDB0.6%——
TEL0.5%——
OC0.5%——
JNJ0.5%——
NEM0.4%——
PFGC0.4%——
HON0.4%——
WDAY0.4%——
SWKS0.4%——
GLOB0.4%——
BIIB0.4%——
TSM0.4%——
HONA0.3%——
NCLH0.3%——
DGX0.3%——
ROKU0.3%——
GRAB0.2%——
LBRT0.2%——
HUMA0.1%——
BAND0.1%——
CHYM0.1%——
BABA0.1%——
GPCR0.1%——
NAVN0.1%——
SDRL0.0%——
FICO0.0%——
FRMI0.0%——
Z0.0%——
TH0.0%——
XYZ0.0%——
ACIC0.0%——
UBS0.0%——
BRKR0.0%——
VEEV0.0%——
SMWB0.0%——
SDGR0.0%——
MGNI0.0%——
CERT0.0%——
PCOR0.0%——
INIO0.0%——
PDD0.0%——
AZN0.0%——
TDW0.0%——
ARGX0.0%——
SYK0.0%——
IMNM0.0%——
COR0.0%——
LLY0.0%——
STE0.0%——
VRTX0.0%——
WAT0.0%——
JCI0.0%——
UNH0.0%——
NTRA0.0%——
ESTA0.0%——
SIBN0.0%——
ABT0.0%——
AVA0.0%——
ADSK0.0%——
GE0.0%——
IR0.0%——
MYRG0.0%——
HUM0.0%——
ELAN0.0%——
ORA0.0%——
THC0.0%——
DNTH0.0%——
QGEN0.0%——
MASS0.0%——
EW0.0%——
CI0.0%——
BIO0.0%——
MCK0.0%——
TNGX0.0%——
ANL0.0%——
RLMD0.0%——

Weighted by reported value in the latest 13F, held until the next filing.

PeriodReturn a yearS&P 500SharpeS&P 500Biggest dropBetaAlpha (t)
Whole backtest13 Jan 2017 to 2 Nov 2026+15.5%+14.8%0.710.72−33.5%0.96+1.3% (0.47)
2018 onwards5 Jan 2018 to 2 Nov 2026+13.6%+13.9%0.600.64−33.5%0.96+0.4% (0.14)
Last three years3 Nov 2023 to 2 Nov 2026+23.9%+21.8%1.311.16−13.9%0.79+5.1% (1.08)
Last year7 Nov 2025 to 2 Nov 2026+17.2%+14.2%1.080.84−6.9%0.44+8.1% (0.77)
DateCompanyAction
7 Aug 2026ZBought
7 Aug 2026VEEVBought
7 Aug 2026UNHBought
7 Aug 2026THCBought
7 Aug 2026TELBought
7 Aug 2026SWKSBought
7 Aug 2026SMWBBought
7 Aug 2026PFGCBought
7 Aug 2026NCLHBought
7 Aug 2026MGNIBought
7 Aug 2026MCKBought
7 Aug 2026LLYBought
7 Aug 2026LBRTBought
7 Aug 2026INIOBought
7 Aug 2026HUMBought
7 Aug 2026HONABought
7 Aug 2026HONBought
7 Aug 2026GRABBought
7 Aug 2026EWBought
7 Aug 2026ESTABought
7 Aug 2026ELANBought
7 Aug 2026DTBought
7 Aug 2026CWTBought
7 Aug 2026CIBought
7 Aug 2026BKNGBought

Dated at the rebalance that made the change.

DateCompanyAction
7 Aug 2026VRDNSold
7 Aug 2026VNETSold
7 Aug 2026TEVASold
7 Aug 2026TARSSold
7 Aug 2026STNESold
7 Aug 2026REGNSold
7 Aug 2026PSIXSold
7 Aug 2026OTISSold
7 Aug 2026ORICSold
7 Aug 2026ORCLSold
7 Aug 2026LZSold
7 Aug 2026LXUSold
7 Aug 2026IRTCSold
7 Aug 2026IRONSold
7 Aug 2026IDYASold
7 Aug 2026GILDSold
7 Aug 2026DXCMSold
7 Aug 2026COLDSold
7 Aug 2026CLPRSold
7 Aug 2026CABASold
7 Aug 2026BSXSold
7 Aug 2026BIOASold
7 Aug 2026AZOSold
7 Aug 2026ALCSold
8 May 2026WLKSold

Dated at the rebalance that made the change.

Backtests are hypothetical and use today's listed companies only, which flatters results. Past performance does not predict future returns. This is research, not investment advice. How we backtest